2 results
Approved WMOCompleted
To assess the benefits and harms of SUP with PPI in adult, critically ill patients in the ICU.
Approved WMORecruiting
The primary objective is reducing treatment-related morbidity and mortality without adversely impacting DFS in Ph+ ALL patients, classified as Standard Risk (SR) based on low minimal residual disease (MRD) at week 10-12 of therapy.Because there is…